Advancement in utilization of magnetic resonance imaging and biomarkers in the understanding of schizophrenia  

作　　者：Aidan K Tirpack Danyaal G Buttar Mandeep Kaur 

机构地区：[1]Department of Psychiatry,Campbell University School of Osteopathic Medicine,Buies Creek,NC 27506,United States [2]Department of Psychiatry and Behavioral Health,Mercyhealth Hospital and Trauma Center,Janesville,WI 53548,United States

出　　处：《World Journal of Clinical Cases》2025年第1期11-15,共5页世界临床病例杂志（英文）

摘　　要：Historically,psychiatric diagnoses have been made based on patient’s reported symptoms applying the criteria from diagnostic and statistical manual of mental disorders.The utilization of neuroimaging or biomarkers to make the diagnosis and manage psychiatric disorders remains a distant goal.There have been several studies that examine brain imaging in psychiatric disorders,but more work is needed to elucidate the complexities of the human brain.In this editorial,we examine two articles by Xu et al and Stoyanov et al,that show developments in the direction of using neuroimaging to examine the brains of people with schizo-phrenia and depression.Xu et al used magnetic resonance imaging to examine the brain structure of patients with schizophrenia,in addition to examining neurotransmitter levels as biomarkers.Stoyanov et al used functional magnetic resonance imaging to look at modulation of different neural circuits by diagnostic-specific scales in patients with schizophrenia and depression.These two studies provide crucial evidence in advancing our understanding of the brain in prevalent psychiatric disorders.

关 键 词：SCHIZOPHRENIA Magnetic resonance imaging Biomarkers NEUROTRANSMITTERS Psychiatric disorders 

分 类 号：R445.2[医药卫生—影像医学与核医学] R749.3[医药卫生—诊断学]